Pre-Submission Review for Psychiatry Papers

Psychiatry reviewers usually ask:

• is the clinical or mechanistic question specific enough?
• are diagnoses, symptom scales, exposure definitions, and time windows clear?
• does the study handle comorbidity, medication exposure, and confounding honestly?
• are causal claims limited to designs that can support them?
• are CONSORT, STROBE, PRISMA, or related reporting expectations met?
• does the paper respect stigma-sensitive language and patient-centered framing?
• does the target journal want clinical psychiatry, epidemiology, neuroscience, genetics, treatment, policy, or public health?
• does the abstract make a claim that the results can defend?

Those questions decide whether the manuscript looks ready or merely readable.

In our pre-submission review work, psychiatry manuscripts most often fail because the central construct is too loose for the journal being targeted.

Diagnostic drift: the title and abstract use a disorder label, but the actual cohort is based on screening scores, registry codes, prescriptions, or proxy definitions.

Scale overclaim: a symptom scale is treated like a clinical diagnosis, or a statistically detectable difference is framed as a patient-meaningful improvement without justification.

Comorbidity fog: anxiety, substance use, neurodevelopmental conditions, sleep, medication exposure, and socioeconomic variables are present but not handled in the story.

Causal language leak: observational data are written as if the exposure produced the outcome. JAMA Network instructions explicitly caution that causal wording belongs to designs that can support it.

Journal-lane mismatch: a biological psychiatry manuscript is aimed at a clinical psychiatry journal, or a clinical services paper is aimed at a mechanistic journal.

JAMA Network instructions ask research authors to follow EQUATOR reporting guidelines and to prespecify primary outcomes and analyses where relevant. They also distinguish randomized clinical trials from observational designs when discussing causal language.

Molecular Psychiatry's author materials emphasize article preparation, supplementary information, figure files, and complete self-explanatory manuscripts. For authors, that means the main article needs to stand on its own. You cannot rely on supplementary tables to rescue an unclear claim.

ICMJE guidance asks authors to prepare manuscripts so methods, ethics, authorship, disclosures, trial registration, and data-related statements can be evaluated by editors and reviewers. Psychiatry papers often carry extra reader sensitivity around consent, vulnerable populations, stigma, and clinical interpretation.

Send the manuscript, target journal, abstract, figures, tables, supplement, reporting checklist, trial registration if relevant, ethics approval language, data availability statement, and prior decision letters if the paper was already reviewed.

For trials, send the protocol and statistical analysis plan. For cohort or registry studies, send variable definitions, exposure windows, inclusion/exclusion logic, missing-data plan, and any sensitivity analyses. For neuroimaging or biomarker studies, send preprocessing and validation details. For qualitative work, send sampling, coding, reflexivity, and ethics details.

A useful psychiatry pre-submission review should include:

• diagnosis and construct verdict
• journal-lane fit
• outcome and scale critique
• causal language check
• confounding and comorbidity critique
• reporting checklist risk
• ethics and stigma-sensitive wording note
• submit, revise, retarget, or diagnose deeper call

The review should name the likely reviewer objection. "Improve clarity" is not enough. A useful comment says, "The paper calls this depression incidence, but the cohort is screening-positive symptoms at one time point."

Before submission, authors often need to:

• narrow a disorder label to match the actual case definition
• separate association from cause
• move medication exposure and comorbidity into the main story
• add a clinically meaningful interpretation of scale changes
• clarify trial registration or prespecified outcomes
• add a reporting checklist
• retarget from a flagship psychiatry journal to a clinical, epidemiology, neuroscience, or specialty venue
• rewrite the abstract so it does not overpromise clinical action

The order matters. Fix construct and inference first, then polish the prose.

When a psychiatry manuscript has multiple risks, fix the layer that controls trust.

1. Construct clarity: define the diagnosis, symptom measure, exposure, and population precisely.
2. Design-to-claim alignment: keep causal language inside the evidence boundary.
3. Outcome meaning: explain why the primary outcome matters clinically, not only statistically.
4. Confounding and comorbidity: address the alternative explanations reviewers will raise.
5. Journal-lane fit: decide whether the paper is clinical psychiatry, biological psychiatry, epidemiology, treatment, policy, or public health.

That order prevents a common mistake: polishing language while the diagnosis or causal claim remains vulnerable.

A psychiatry editor is not only asking whether the topic is interesting. The first page has to show what population was studied, what clinical construct is being measured, why the outcome matters, and why the target journal's readers need this paper now.

If the opening paragraph says "depression" but the methods use a broad symptom threshold, the editor starts reading defensively. If the abstract says "risk factor" but the design is cross-sectional, the editor expects reviewers to object. If the introduction spends too long on disease burden and too little on the exact evidence gap, the paper feels less ready than it may actually be.

For psychiatry manuscripts, first-page trust comes from precision. Name the construct, name the design, name the patient or population lane, and keep the claim inside the evidence.